|
Volumn 34, Issue 4, 2010, Pages
|
Clonal evolution at leukemic relapse of multiple myeloma (secondary plasma cell leukemia) responding to re-treatment with bortezomib-based therapy. A case record
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLOPURINOL;
BORTEZOMIB;
CD19 ANTIGEN;
CD38 ANTIGEN;
CD56 ANTIGEN;
DEXAMETHASONE;
DOXORUBICIN;
ERYTHROPOIETIN;
MELPHALAN;
PREDNISONE;
SYNDECAN 1;
THALIDOMIDE;
AGED;
BONE MARROW EXAMINATION;
CANCER GROWTH;
CASE REPORT;
CHROMOSOME 13;
CHROMOSOME ABERRATION;
CHROMOSOME ANALYSIS;
CLONE;
CYTOPENIA;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
FEMALE;
FLOW CYTOMETRY;
GENETIC ASSOCIATION;
HUMAN;
LETTER;
LEUKEMIA RELAPSE;
LEUKOCYTOSIS;
MAINTENANCE THERAPY;
MULTIPLE CYCLE TREATMENT;
MULTIPLE MYELOMA;
PLASMA CELL LEUKEMIA;
PRIORITY JOURNAL;
PROTEINURIA;
RETREATMENT;
TREATMENT RESPONSE;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BORONIC ACIDS;
CLONE CELLS;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
LEUKEMIA, PLASMA CELL;
MULTIPLE MYELOMA;
PYRAZINES;
RECURRENCE;
|
EID: 76749157360
PISSN: 01452126
EISSN: None
Source Type: Journal
DOI: 10.1016/j.leukres.2009.10.008 Document Type: Letter |
Times cited : (7)
|
References (6)
|